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Autologous transplantation 
of intestine-isolated glia cells 
improves neuropathology 
and restores cognitive 
deficits in β amyloid-induced 
neurodegeneration
Giuseppe Esposito1,*, Giovanni Sarnelli2,*, Elena Capoccia1, Carla Cirillo3, Marcella Pesce2, 
Jie Lu4, Gaetano Calì5, Rosario Cuomo2 & Luca Steardo1
Alzheimer’s disease (AD) is characterized by chronic deposition of β-amyloid (Aβ) in the brain, 
progressive neurodegeneration and consequent cognitive and behavioral deficits that typify the 
disease. Astrocytes are pivotal in this process because they are activated in the attempt to digest 
Aβ which starts a neuroinflammatory response that further contributes to neurodegeneration. The 
intestine is a good source of astrocytes-like cells-referred to as enteric glial cells (EGCs). Here we 
show that the autologous transplantation of EGCs into the brain of Aβ-injected rats arrested the 
development of the disease after their engraftment. Transplanted EGCs showed anti-amyloidogenic 
activity, embanked Aβ-induced neuroinflammation and neurodegeneration, and released neutrophic 
factors. The overall result was the amelioration of the pathological hallmarks and the cognitive 
and behavioral deficits typical of Aβ-associated disease. Our data indicate that autologous EGCs 
transplantation may provide an efficient alternative for applications in cell-replacement therapies to 
treat neurodegeneration in AD.
A chronic, progressive imbalance in either Aβ production or removal rates due to malfunctioning resident astro-
cytes in the brain plays a crucial role in AD progression1,2.
In response to Aβ deposition, resident astrocytes are activated, proliferate and migrate to the site of amy-
loid plaques to digest Aβ 3,4. However, during this process, astrocytes also release proinflammatory factors that 
intensify the progressive neuronal degeneration and loss in the Alzheimer’s disease (AD) brain5–7. So far, few 
attempts have been made with the possible use of astrocyte-targeted treatments, with noticeable success in animal 
models of AD4,6–8. In particular, the idea of replacing malfunctioning astrocytes with brand new ones, proposed 
by Pihlaja et al.4, is very challenging and bears a huge therapeutic potential. However, many limitations exist 
on allogenic transplantation and its potential applications to humans9,10. A possible strategy could be the use of 
astrocytes-like cells, namely enteric glial cells (EGCs) in the intestine, as these share many morphological and 
functional features with cerebral astrocytes11. Here we evaluated the efficacy of the autograft of EGCs in the brain 
of a rat model of Aβ -induced AD (Fig. 1a). We first demonstrated astrocyte activation following the infusion 
of Aβ (1–42) peptide in rat brains. Specifically, after Aβ -plaque deposit and growth in both the cortex and hip-
pocampus (Fig. 1b) we found that astrocytes (GFAP positive cells) surrounded Aβ deposits, confirming previous 
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evidence3. In transplanted rats, where the PKH26GL marker indicates the successfully engrafted cells, EGCs 
migrate and visibly surround Aβ (1–42) plaques over the time, thereby behaving like resident astrocytes (Fig. 2a,b). 
In addition, and differently to astrocytes, engrafted EGCs significantly and time-dependently reduced the uptake 
of 11C-labeled Pittsburgh Compound-B ([11C]-PIB), as assessed by PET scans using the [11C]-PIB radiotracer, 
which specifically binds fibrillary Aβ plaques12 (Fig. 1d,e); accordingly, the size of Aβ burden (Fig. 1c) and plaques 
size (Fig. 2c,d) were significantly decreased, as shown by the quantitative analysis in brain slices.
To evaluate whether the effect of EGCs was due to their ability to digest Aβ aggregates, we measured in vitro 
the expression of specific proteases, namely neprilysin and Endothelin-converting enzyme-2 (ECE-2), which are 
known to be involved in amyloid clearance13,14. The result was a significant upregulation of both proteases when 
EGCs cultures were exposed to Aβ (1–42) peptide (Supplementary Fig. 1). This result was confirmed in vivo in 
transplanted rats, where EGCs overexpressed neprilysin and ECE, and induced Aβ degradation with a significant 
peak at eight weeks (Supplementary Fig. 2). As evidence of Aβ (1–42) deposit, we looked at the size and density of 
neurofibrillary tangles (NFTs) in rat brains. In line with the above results, we found that the engraftment of EGCs 
caused a marked reduction of NFTs density, with a peak at eight weeks following transplantation (Fig. 3a,b). 
Together with the migration to the site of Aβ accumulation, to participate to the clearance of the plaques, reactive 
Figure 1. Autologous EGCs induced Aβ plaques degradation. (a) Diagram showing Aβ (1–42) peptide infusion, 
EGCs isolation from the appendix, their transplantation in rat brain, and the time schedule for in vitro and  
in vivo measurements. (b) The injection of Aβ (1–42) peptide causes a time-dependent amyloid deposition in 
frontal cortex and hippocampus of treated rats; in EGCs transplanted rats a time-dependent reduction of Aβ 
plaques was instead observed (n = 10 per group; congo red staining, scale bar: 500 μm). (c) The graphs show 
that Aβ burden time-dependently increased in sham versus vehicle-treated rats and that EGC transplantation 
resulted in a significant inhibition of Aβ accumulation. In the frontal cortex (left panel) and the hippocampus 
(right panel) Aβ burden was significantly higher in sham (black bars) than in vehicle-treated rats (white 
bars) at 4 and 8 weeks (***P < 0.001), while in EGC-transplanted rats it was significantly reduced (°P < 0.05 
and °°°P < 0.001 vs. sham group). (d) Representative scans of 11C-labeled Pittsburgh Compound-B positron 
emission tomography; Standardized uptake values (SUV) images of Aβ binding within the region of interest 
(ROIs) in the frontal cortex (COR) and hippocampus (HIP) of rats (n = 6 per group). (e) Relative SUVs for 
selected ROIs in the cortex (left panel) and hippocampus (right panel). Data were expressed as mean ± SEM; 
**P < 0.01, ***P < 0.001 vs. vehicle; °P < 0.05; °°° P < 0.001 vs. sham; two-way ANOVA.
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Figure 2. Transplanted EGCs migrate to the site of Aβ plaques deposits. (a,b) Immunofluorescence analysis 
shows that the injection of Aβ (1–42) peptide causes the accumulation of resident astrocytes (GFAP, green) around Aβ 
plaques (blue) in the frontal cortex (a) and the hippocampus (b) of sham compared to vehicle-treated rats. In  
transplanted rats, EGCs (PKH26GL, red) time-dependently migrate to the sites of Aβ plaque deposits in both brain 
areas and degrade Aβ aggregates at weeks 4 and 8 after injection (n = 10 for each group; scale bar: 20 μm).  
(c,d) Plaques size was significantly higher in sham than in vehicle-treated rats at all time points (*P < 0.05 and 
***P < 0.001), but in EGC-transplanted rats it was significantly reduced in the cortex (c) and the hippocampus  
(d) at 4 weeks and 8 weeks post transplantation (°P < 0.05, °°P < 0.01 and °°°P < 0.001 vs. sham group, respectively). 
Results were expressed as mean ± SEM of n = 6 experiments in triplicate per group. Statistical analysis was performed 
using parametric one-way ANOVA and Bonferroni’s post-test; P < 0.05 was considered significant. (e,f) Engrafted 
EGC time-dependently migrate to the sites of Aβ plaque deposits in both in the frontal cortex (e) and the hippocampus 
(f), as revealed by progressive reduction of mean distance from the Aβ deposits.
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astrocytes also secrete pro-inflammatory mediators and neurotoxic factors that amplify the neurodegeneration 
described in AD brain15. Based on the evidence that different mediators and cytokines increase in human AD 
brain and in animal models16, we measured the expression of COX-2, Iba-1, GFAP and phosphorylated tau 
Figure 3. Autologous EGCs engraft reduces Aβ-dependent neuroinflammation. (a,b) Immunohistochemistry  
of phospho-tau (pSer202) in brain slices shows a significant and timely-course dependent increase in protein staining 
in sham (n = 10) versus vehicle-treated rats (n = 10) in frontal cortex (a) and hippocampus (b). Scale bar: 50 μm.  
(c,d) The graphs show the significant and time-dependent increased expression of Iba-1, COX-2, GFAP and 
phosphor-tau protein in the frontal cortex (c) and the hippocampus (d) of sham compared to vehicle-treated rats 
(n = 10) (all P < 0.001). EGC transplantation caused a significant decrease in Iba-1, COX-2, GFAP and phosphor-
tau protein expression along the time point intervals in both frontal cortex (c) and hippocampus (d) (°P < 0.05 and 
°°P < 0.001 vs. sham group). (e,f) The graphs show the level of pro-inflammatory cytokines measured by ELISA in the 
frontal cortex (e) and hippocampus (f) of sham, vehicle-treated and EGC-transplanted rats. Note the significant and 
time-dependent increase in TNF-α , PGE2 and IL-6 release (*P < 0.05 and ***P < 0.001) in sham compared to vehicle-
treated rats. Autologous EGCs engraft caused a significant and time-dependent decrease in TNF-α , PGE2 and IL-6 
release (*P < 0.05 and ***P < 0.001) in the frontal cortex (e) and the hippocampus (f) of EGC-transplanted versus 
sham rats. Results are expressed as mean ± S.E.M of n = 5 experiments in triplicate for each animal group. Statistical 
analysis was performed using parametric one-way analysis of variance (ANOVA) and multiple comparisons were 
performed by Bonferroni’s post-test. Values of P < 0.05 were considered significant.
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proteins as well as the release of TNF-α , PGE2 and IL-6. After the infusion of Aβ (1–42) peptide in rat brains we 
found that the expression of proinflammatory mediators and cytokines was dramatically increased in the cortex 
and hippocampi, thus confirming previous data7,15,16. In contrast, after transplanting the EGCs, we measured a 
significant attenuation of Aβ -induced neuroinflammation, as shown by the reduced expression of COX-2, Iba-1, 
GFAP and phosphorylated tau protein, along with a significant decrease in TNF-α , PGE2 and IL-6 (Fig. 3c–f). 
In addition to pro-inflammatory cytokines, many other proteins are released into the brain interstitial space, 
possibly accounting for the neurotoxicity during AD progression17. Aquaporin 4 (AQP-4) has been identified as 
having a role in the extracellular elimination of ‘waste’ products in the brain, such as Aβ aggregates18. AQP-4 is 
expressed on the endfeet of astrocytes and is part of the so called ‘glymphatic unit’19. Thus, we wondered whether 
AQP-4 was involved in EGCs-mediated Aβ clearance. We show here that the expression of AQP-4 was increased 
at the brain-liquor interface after EGCs transplantation (Supplementary Fig. 3a–c). Although more sophisticated 
approaches are needed to demonstrate that EGCs-associated AQP-4 upregulation participates to the elimination 
of proteases-degraded amyloid plaques, our data showing that in EGC-transplanted rats there is a significant 
reduction of tissue Aβ and an increased excretion in cererebrospinal fluid (Supplementary Fig. 3d,e) likely sup-
port what previously hypothesized by Weller and colleagues20.
There is evidence that rat primary EGCs are able to release neurotrophines in vitro, indicating that these cells 
have the potential to promote neurogenesis, or at least, to have neurotrophic effects21. Here we confirm these data, 
showing that EGCs maintain this ability also in vivo. Starting at two weeks post-transplantation and reaching a 
peak at eight weeks, the concentration of NGF, BDNF and GDNF was significantly higher in EGCs-transplanted 
rats (Fig. 4a,c), with a close contact between transplanted EGCs and neurotrophines-expressing fibers being evi-
dent at eight weeks (Fig. 4b). Interestingly, engrafted EGCs appear to promote neurogenesis specifically in the 
areas of Aβ (1–42)-injection. We indeed found a significantly increased expression of Doublecortin X, a marker of 
newborn neurons, at eight weeks after EGCs transplantation (Fig. 4d,e); at the same time point, we also found a 
significantly increased number of BrdU-labeled cells (Fig. 4f,g), which supports the hypothesis that EGCs may 
affect, at least partially, the neurogenesis.
In recent years, stem cell transplantation has been proposed for the treatment of neurodegenerative disor-
ders22. Generating human pluripotent stem cells raises ethical and safety concerns, which strongly limit their 
therapeutic potential in humans. Cultured EGCs may theoretically contain neuronal progenitors that could have 
stem cell-like profile. To check whether the results we observed were due to adult EGCs or to the presence of neu-
ronal or glial progenitors, we stained EGC cultures with SOX-2 and CD133, which are markers of stem cells23,24. 
We found that EGCs did not express either SOX-2 or CD133, while they did express S100B and vimentin as 
markers of adult EGCs (Supplementary Fig. 4).
Aβ -induced neurodegeneration is known to induce cognitive and behavioral deficits25,26. To test whether 
EGCs transplantation could improve cognitive and behavioral deficits we performed a Morris Water Maze test to 
measure learning skills and spatial memory retention in rats27. During the retention test, control animals spent 
a significantly longer time in the quadrant than Aβ (1–42)-infused rats. Interestingly, after EGC engraftment a sig-
nificant increase in the time spent on, and the number of crossings over the platform position was also observed 
(Fig. 5a,b). Similar results have been reported for the object recognition test, which is used to assess recognition 
memory in experimental models of neurodegenerative diseases28. During the trial test, only an impairment in 
the recognition of the object was observed in Aβ (1–42)-injected rats, while after EGC transplantation a significant 
amelioration of the performance was measured (Fig. 5c).
In conclusion, this study provides the first evidence on how EGCs, likely because of their similarity with brain 
astrocytes, may represent a valid source that, when transplanted into the brain of rats with AD-like neuropathol-
ogy can reach damaged areas and promote structural and functional neuronal recovery, likely by secreting neuro-
trophines in their surrounding environment in concentrations that can prompt neurogenesis. Although further 
studies are needed to better characterize EGCs in the light of the new acquisitions regarding their heterogeneity 
in different animals29,30, many considerations further support the possible translation of our results into humans. 
First, the isolation of mature EGCs is safe and easily performed, as it does not require any invasive neurosur-
gical procedure. As brain biopsy in humans has many risks and limitations, the appendicectomy is a quite safe 
procedure and would allow to harvest adult EGCs from the nervous system in the gut (the ENS), as previously 
described31. Second, transplanted EGCs were autologous with a virtually absent risk of immune-mediated graft 
rejection. Third, transplantation of EGCs into the brain resulted in a substantial improvement of Aβ burden and 
of the associated neurocognitive decline at a two-month follow-up.
In this perspective, this study lays the foundation for the use of autologously transplanted EGCs in humans 
and paves the way for new opportunities for the clinical use of astrocyte-like cells based therapies to treat AD and 
other incurable neurodegenerative disorders in humans.
Methods
Cell culture medium, chemicals and antibodies. Dulbecco’s Modified Eagle’s Medium (DMEM)-F12, 
sterile PBS 1X, trypsin EDTA, antibiotic/antimycotic mixture, protease, collagenase, PKH26GL tracker dye, 
as well as other chemicals were purchased by Sigma (Sigma-Aldrich, Milan, Italy); Aβ (1–42) peptide was from 
Tocris (Bristol, UK); cell culture plates and other plastic-consumable materials were from Corning (Lowell, 
MA, USA). Congo-red, paraformaldehyde and other reagents for immunohistochemistry and histology were 
from Sigma; mounting medium for immunohistochemistry and immunofluorescence samples Eukitt was from 
Bioptica (Milan, Italy). Milk blocking buffer was from Sigma (Sigma-Aldrich, Milan, Italy). The following anti-
bodies: mouse anti-S100B, rabbit anti-SOX-2, rabbit anti-vimentin, rabbit anti-CD133, anti-COX-2, rabbit pol-
yclonal anti-GFAP, rabbit polyclonal anti-nerve growth factor (anti-NGF) rabbit polyclonal anti-Glial Derived 
Neurotrophic Factor (anti-GDNF), rabbit polyclonal anti-Brain Derived Neurotrophic Factor (anti-BDNF), 
rabbit polyclonal Anti Doublecortin X (anti-DCX); rabbit polyclonal anti-aquaporin-4 antibody (anti AQP-4), 
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rabbit monoclonal anti-NeuN (anti-NeuN), rabbit polyclonal anti-Bromodeoxyuridine (anti-BrdU) and rabbit 
polyclonal anti β -actin were all from Abcam (Abcam, Cambridge, UK). Rabbit polyclonal Anti phosphor-tau 
(pSer202) was from Sigma, (Sigma-Aldrich, Milan, Italy); anti-Iba-1 was from Santa Cruz (Santa Cruz Biotech. 
Inc., Costa Mesa, CA, USA); rabbit anti-endothelin-2 converting enzyme (anti-ECE-2) was from Bioss Inc, 
(Woburn, MA, USA) and rabbit anti anti-neprilysin was purchased from Novus Biological Europe (Cambridge, 
UK). Secondary FITC or TRITC-conjugated species-specific antibodies and DAPI were from SIGMA (Sigma-
Aldrich, Milan, Italy). Specific horseradish peroxidase (HRP)-conjugated secondary antibodies for Western 
blot were from Dako (Dako, Golstrup, DK). Other reagents for Western blot detection and analysis were from 
Figure 4. Autologous EGCs engraft increases neurotrophines release and neurogenesis. (a) Hippocampal 
release of NGF, BDNF and GDNF. A time-dependent decrease of neurotrophines was observed in sham 
compared to vehicle rats (n = 8 and 6, respectively), with the lowest value at 8 weeks (**P < 0.01); in 
EGCs-transplanted rats the release of neurotrophines progressively increased, being maximum at 8 weeks 
(°°°P < 0.001; n = 8). (b) Immunofluorescence of BDNF, GDNF and NGF (all in green) in dentate gyrus 
(DG) of isolated hippocampi; in EGCs-transplanted rats the close contact between PKH26GL-positive EGCs 
(red) and neurotrophines-expressing fibers (green) is magnified in the squares (blue: DAPI staining of nuclei; 
magnification: 10 and 25X; scale bar: 100 and 10μm). (c) Quantitative analysis of BDNF, GDNF and NGF 
showing that Aβ -associated reduction of neurotrophines fluorescence was significantly restored in EGC-
transplanted rats (**P < 0.01 vs vehicle and °°°P < 0.001 vs. sham; n = 6 per group). (d) Immunofluorescence 
of EGC (PKH26Gl, red), Doublecortin X (DCX, green) and DAPI (blue) in DG and subventricular zone (SVZ) 
showing the reduced neurogenesis in sham compared to vehicle rats (n = 8, respectively). In EGC transplanted 
rats (n = 8) the increased DCX immunopositivity was evident; a detail of the contact between EGCs and DCX  
arborizations is magnified in the square (magnification: 10 and 25X; Scale bar: 100 and 10 μm). (e) Quantitative 
analysis of positive DCX neurons in DG (upper) and SVZ (lower). The amount of DCX neurons was 
significantly decreased in sham rats, but in EGC-transplanted there was a significant increase in DCX percent 
(*P < 0.05 and °°°P < 0.001, respectively). Data are representative of mean ± S.E.M of n = 5 experiments in 
triplicate for each animal group; statistical analysis was performed using ANOVA and Bonferroni’s post-test; 
values of P < 0.05 were considered significant. (f) Immunofluorescence analysis of NeuN (red) and BrdU (green) 
in DG. At 8 weeks, BrdU positivity was reduced in sham rats, but it was increased in EGC-transplanted rats 
(magnification: 10X; scale bar: 100 μm). (g) Quantitative analysis showed that the percentage of NeuN/BrdU 
co-expressing neurons was significantly reduced in the sham group (*P < 0.05 vs. vehicle); in the transplanted 
group, NeuN/BrdU immunoreactivity was significantly increased (°°P < 0.01 vs sham), likely suggesting a 
remarkable rescue of neurogenesis.
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Amersham (Milan, Italy) and Biorad Laboratories (CA, USA). Amyloid Plaque Stain Reagent Amylo-Glo® RTD™ 
was from Biosensis (Thebarton, Australia). Enzyme-linked immunosorbent assay (ELISA) kits for the quantifica-
tion of tumor necrosis factor-α and interleukin-6 (IL-6), Beta amyloid 1–42 (Aβ -42) were from Life technologies 
(Invitrogen, Life tech. Monza, Italy); PGE2 ELISA kit was from Abcam (Cambridge, UK); ELISA kit for GDNF 
and NGF were from Biosensis (Thebarton, Australia); BDNF ELISA kit was obtained from Mybiosource (San 
Diego, CA, USA).
Animals and surgical procedures. Adult male Sprague-Dawley rats (200–250 g) were from Charles 
River (Calco, Italy). Animals were housed in a pathogen-free barrier facility under a 12-h light/dark cycle, with 
ad libitum access to food and water. Animals were randomly divided into two groups receiving either toxic Aβ 
1–42 peptide (n = 120) or its vehicle infusion (n = 60) represented by artificial sterile cerebrospinal fluid (CSF) 
in a solution consisting of (in mM): 119 NaCl, 26.2 NaHCO3, 2.5 KCl, 1 NaH2PO4, 1.3 MgCl2, 10 glucose. Aβ 
infusion was performed through a cannula connected to a mini-osmotic pump device (Alzet 2002, Alza, Palo 
Alto, CA, USA) and implanted in the right cerebral ventricle according to Paxinos and Watson atlas coordinates 
(AP-0.3 mm, L 1.2 mm, V 4.0 mm)32. Aβ 1–42 was continuously infused into the lateral ventricle at a rate of 
300 pmol12 μl−1/day−1 in the 20 days following its implantation, and left in place for further transplantation (see 
below). Under anesthesia, after stereotaxic surgery, Aβ -infused animals underwent appendectomy according to 
Delibegovic et al.33. Rats were gently removed from stereotaxic Kopf apparatus, secured with an adhesive band 
and placed on the surgical table in the supine position. The abdomen of the animal was shaved and disinfected 
with povidone-iodine solution and dried with gauze. Laparotomy was performed using a median incision. The 
caecum-appendix was identified and dissected and rapidly placed in sterile Krebs. Rat abdomen was then closed 
with sutures; recovery was quick and optimal and no antibiotic treatment was used before, during, or after the 
experiment. During the entire observational period, all animals were checked for local and systemic complica-
tions following the double-surgery. All procedures were approved by La Sapienza University Ethics Committee. 
Figure 5. ECG transplantation improves Aβ-induced cognitive and behavior deficits. Morris water maze 
(MWM) tasks were performed on vehicle, sham and EGC transplanted animals at 2, 4 and 8 weeks post 
transplantation. (a) Time spent (measured in seconds) in the target quadrant (*P < 0.05 vs. vehicle; °P < 0.05 
vs. sham; two-way ANOVA). (b) Number of crossings over the target quadrant was measured for 120 seconds 
at day 7 after the last acquisition test. MWM results shows that the sham group progressively decreased the 
time spent in the target quadrant and the number of crossings through the platform during the time course, 
compared to the vehicle group (*P < 0.05). EGC transplantation caused a progressive increase in the average 
time spent in the target quadrant resulting in a parallel increase in number of crossing on the platform; such 
increase began to be significant at week 4 and remained until week 8 post transplantation (°P < 0.05). Results 
presented in the graphs are representative of the mean ± S.E.M; n = 10 animals per group. (c) To assess 
recognition memory, object recognition task was performed on vehicle, sham and transplanted animals at 2, 
4 and 8 weeks post EGC transplantation. Recognition index (RI) defines the ratio of time spent exploring the 
novel object over the total time spent exploring both familiar and novel objects. In vehicle rats a significant 
increase in novel object RI was observed versus known object at all the time points (*P < 0.05). The same 
RI evaluation demonstrated non-significant variations in sham rats, whereas EGC transplantation almost 
completely restored the RI observed in vehicle rats (°P < 0.05). RI percent values were expressed for familiar and 
novel objects during the test task (after 3 h delay). Data are expressed as means ± SEM of n = 10 experiments.
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Animal care was in compliance with the IASP and European Community (EC L358/1 18/12/86) guidelines on the 
use and protection of animals in experimental research.
Isolation and culturing of EGCs from appendices. According to the procedure described by Cirillo 
et al.31, after surgical removal, appendices were placed in a cold oxygenated sterile Krebs solution containing 
(in mM): 117 NaCl, 4.7 KCl, 1.2 MgCl2 6 H2O, 1.2 NaH2PO4, 25 NaHCO3, 2.5 CaCl2 2 H2O, and 11 glucose 
under carbogen (5% CO2, 95% O2) atmosphere equilibrated at pH 7.4. Appendices were then longitudinally 
cut along the mesenteric border and pinned flat, mucosa up, inside a dissection dish containing an ice-cold 
Krebs solution that was replaced every 5 min. The tissue was dissected by carefully removing the mucosa and 
the circular muscle to expose the myenteric plexus. After removal, the myenteric plexus was enzymatically 
digested for 30 min at 37 °C in a solution containing protease (1 mg/ml) and collagenase (1.25 mg/ml). After 
this phase, the enteric ganglia were picked up and plated onto coverslips in 6-well culture plates. An amount of 
Dulbecco’s Modified Eagle Medium (DMEM) F-12, supplemented with 10% heat-inactivated calf serum (FCS) 
and 1% antibiotic-amtimycotic mixture was added to the cells. After 2.5 weeks, EGC cultures were purified using 
Dynal-Magnet (Miltenyi Biotec GmbH, Bergisch Gladbach, Germany), according to the manufacturer’s instruc-
tions and to the method previously described31. The separation step with dynabeads was performed twice in order 
to eliminate residual fibroblasts/smooth muscle cells within the culture. The resulting EGC enriched cultures 
(∼ 1000 × 104 cells/ml) were characterized by immunofluorescence.
Characterization of EGCs cultures. Isolated and cultured EGCs were washed with 1 × phosphate buffer 
saline (PBS) and fixed with 4% paraformaldehyde in 1 × PBS. EGCs were blocked in 10% albumin bovine serum 
0.1% Triton-PBS solution (blocking buffer) for 90 minutes at room temperature; thereafter they were incubated 
for 1 hour at room temperature with the following antibodies diluted in 10% w/v milk blocking buffer: mouse 
anti-S100B (1:500), rabbit anti-SOX-2 (1:400), rabbit anti-vimentin (1:300), rabbit anti CD133 (1:300). Finally, 
EGCs were incubated for 1 hour at room temperature with the appropriate fluorescent secondary antibodies. 
Nuclei were stained with DAPI (1:5,000, Sigma, Milan, Italy). Pictures were taken using a camera (Nikon Digital 
Sight DS-U1) connected to a microscope (Nikon Eclipse 80i; Nikon Instruments Europe) provided with the 
proper fluorescence filters. Slides were analyzed with a microscope (Nikon Eclipse 80i), and images were cap-
tured at 10× and 20× magnification with a high-resolution digital camera (Nikon Digital Sight DS-U1). In some 
experiments, analysis of immunopositive cells was performed using a specific digital system (NIS-Element Basic 
Research version 2.30 software).
EGCs tracking with viable PKH26GL dye. In order to mark and localize transplanted EGCs into the 
receiving brains with a nontoxic dye, EGCs were labeled with the rhodamine-labeled fluorescent dye PKH26GL 
Red Fluorescent Cell Linker Kit for General Cell Membrane Labeling following the manufacturer’s instructions. 
PKH26GL is a red fluorochrome with detection systems in immunofluorescence analysis; its capability to track 
cells before transplantation has been tested in other studies with stem cells and its stability is favorable for long 
term in vivo studies. Confluent EGCs were detached by trypsin: EDTA (1:25), counted and plated in 6-multiwell 
plates at a density of 5 × 104 cells/ml and allowed to adhere for 24 h. For autologous transplantation, each single 
EGCs strain isolated and cultured was collected and strictly marked and catalogued before being tracked and 
re-injected in the same animal from which it was originated. For PKH26GL tracking, after trypsinization, EGC 
were washed with DMEM/F12 medium and incubated for 3 min with a 1:250 PKH26GL dye. After this proce-
dure, cells were centrifuged again, the excess of fluorescent dye was removed and, immediately before transplan-
tation, the pellet was re-suspended in artificial CSF.
Transplantation of EGCs in rat brains. As above described, during the 20 days of infusion, we were able 
to collect for each single appendicectomized rat a significant amount of auto-transplantable EGCs. After pre-
liminary purification and characterization of EGCs, animals were ready for autologous transplantation. Before 
this, Aβ infusion was stopped and infused rats (n = 60) were divided in two experimental groups, depending 
on whether or not they received autologous EGCs transplantation. For transplantation, 5 × 105/μl EGCs were 
tracked with PKH26GL, suspended in a volume of 10μl CSF and infused for 24 h through the same cannula left 
in place with Alzet osmotic pump (as above described) these animals were thus conventionally considered as 
“transplanted” group. An equal volume of CSF was infused in the remaining rats (n = 60) without cell infusion, 
and this group was thus considered as “sham” group, as internal control. Both sham and transplanted groups 
were thus matched with the third rat group, which was initially exposed to vehicle infusion, and considered as 
“vehicle-treated” group. To minimize the discomfort and/or risk of infection after transplantation, at the end of 
infusion the cannula was removed.
Morris water maze test. Animals were trained in a pool filled with water kept at 25 ± 1 °C to avoid hypo-
thermia. White-colored water was poured into a circular pool (diameter, 120 cm; height, 40 cm), and a white 
platform (10 × 6.5 cm, 21.5 cm high) was placed 1.0 cm below the water level in the middle of a fixed quadrant. 
According to the experimental design, vehicle, sham, and EGC-transplanted (n = 10 each group, for each time 
course interval) rats underwent behavioral tasks at different time points after the transplantation. First, acqui-
sition trials were performed four times daily for 7 days to reach a steady state of escape latency. The rats were 
allowed to swim freely for 120 s and were left for an additional 30 s on the platform. The intertribal interval dur-
ing four trials was 75 min. Start positions set at each limit between quadrants were randomly selected for each 
animal. Rats failing to find the platform were placed on the platform manually. Memory-retention tests were 
performed at the seventh day after the last training session. The platform was removed and each rat was allowed 
a free 120 s swim. The number of crossings over a point where the platform had been was counted by replay using 
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a video camera set above the center of the pool and connected to a video tracking system (Ethovision 3.0; Noldus 
Information Technology BV, Wageningen, Netherlands).
Object recognition test. Object recognition test was carried out in an open-field arena constructed of 
black Plexiglas (50 cm × 40 cm × 63 cm). Depending upon the experimental design, (n = 10 each group, for each 
time course interval) rats deriving from the vehicle, sham or EGC-transplanted group at different time course 
post-transplantation intervals underwent an 8-minutes acquisition trial, during which the animal was placed in 
the open field in the presence of two identical objects identified as A, represented by a cube or ball and located 
at 15 cm from the arena wall (acquisition task). Upon completion of the exploration time, animals were returned 
to their respective cages for 3 hours. After the retention interval, rats were placed back into the box and exposed 
to the known object A and to a novel object B for additional 8 minutes (test task). The objects were placed in the 
same locations as the previous ones. The position of the novel object was randomly chosen to avoid preferences 
not based on novelty. Exploratory behavior was considered with the animal directing its nose toward the object 
closely (< 2 cm), and the amount of time spent exploring each of the two objects was thus recorded. To measure 
the recognition memory, a recognition index was calculated as the amount of time exploring the familiar object 
(TA) or the novel object (TB) divided by the total time spent exploring both objects and multiplied by 100, 
according the following formula: [TA or TB/(TA + TB)] × 100. In the acquisition and retention trials, if the explo-
ration time was <30 s and <15 seconds, respectively, the rats were excluded from the trial.
Pittsburg compound positron emission tomography (PET) scan. At the end of the behavioral test, 
in the different experimental groups included in the time course, PET scan was performed on rats (n = 6) after 
behavioral studies at time points 2-4-8 weeks post EGC-transplantation. After initial anesthesia, (5% isoflurane in 
O2/N2O (3:7)) rats were transferred into a sound-attenuated chamber surrounded by a Faraday cage. Inhalation 
anesthesia was sustained during the whole procedure (2% isoflurane) and body temperature was maintained at 
37 °C. Rats were tail-injected with 1.5 mCi Pittsburg compound B [11C]-PIB. Micro-PET imaging was performed 
using a micro-PET R4 rodent model scanner (CTI Concorde Microsystems, Knoxville, TN, USA). Images were 
reconstructed using a maximum posteriori probability algorithm. Corrections for dead time, random scattering 
and attenuation were made for each scan. The drawing region of interest analytical technique was used to obtain 
the averaged pixel counts of each PET image. According to Thie34 the standardized uptake value (SUV) is the 
relative measure of FDG uptake. The basic expression for SUV is: SUV = r(a′/w) where r is the radioactivity 
concentration [kBq/ml] measured by the PET scanner within a region of interest (ROI), a′ is the decay-corrected 
amount of injected radiolabeled FDG [kBq], and w is the weight of the subject (rat) [g], which is used a surrogate 
for a distribution tracer volume.
CSF sampling for Aβ quantification. Immediately following PET procedure, under deep anesthesia, 
before euthanasia, percutaneous CSF collection was obtained by stereotaxic-driven puncture in the cisterna 
magna of the rats, accordingly to procedure described by Mahat et al.35 A mean amount of 100 μl of CSF was 
collected from each procedure.
Post-mortem brain characterization. After behavioral testing and PET scan and CSF sampling, animals 
were sacrificed by overdosing with pentobarbital and perfused intra-cardially with 200 ml of 0.1% NaNO2 in 
phosphate buffer. For histological analysis (n = 10 animals from each group), brains were fixed in 4% paraformal-
dehyde (pH 7.4) for 24 h and subsequently incubated for 24 h in 30% sucrose for cryoprotection. Coronal sections 
of the brain measuring 30 μm in thickness were obtained with a cryosectioning microtome and stored at 4 °C in 
PBS until staining. A series of five equally spaced tissue sections spanning the entire hippocampus and frontal 
cortex areas were then selected for histological and immunohistochemical analysis for neurofibrillary tangles 
(NFTs) formation. For biochemical analyses (western blot, ELISA) (n = 10 animals from each group) brains were 
sampled, snap frozen in liquid nitrogen and stored at − 80 °C until processing.
Aβ plaques detection and NFTs staining in brain slices. Aβ plaques were identified by staining with 
Congo red36. Hippocampal and frontal cortex sections were treated with sodium chloride solution (sodium 
chloride-saturated 80% alcohol containing 0.01% sodium hydroxide) for 20 min at room temperature, then 
stained with Congo red saturated sodium chloride solution for 1 h and finally dehydrated in absolute alco-
hol. Free-floating immunohistochemistry for NFTs detection was performed to stain phospho-tau (pSer202). 
Hippocampal and frontal cortex sections were incubated overnight with primary antibodies, then exposed to 
biotinylated secondary antibodies and finally incubated in horseradish peroxidase complex followed by diamin-
obenzidine (DAB). Sections to be compared were processed simultaneously under the same conditions to reduce 
variability during processing37.
Immunofluorescence of brain slices. Immunofluorescence was performed on frontal cortex and hip-
pocampal coronal sections with adjacent slices derived from the different experimental groups. Samples were 
blocked in 10% albumin bovine serum 0.1% Triton-PBS solution for 15 min and then incubated for 1 h with dif-
ferent antibodies depending from the experimental plan. Both coronal and hippocampal sections were incubated 
with the appropriate antibodies: rabbit anti-GFAP (1:500), rabbit anti-NGF, (1:200) rabbit anti-GDNF (1:250); 
rabbit anti-BDNF (1:250), rabbit anti-DCX (1:300); rabbit anti-NeuN (1:300); rabbit anti-BrdU (1:200); rabbit 
anti-aquaporin-4 (anti-AQP-4 1:250), rabbit anti-ECE-2 (1:250), rabbit anti-neprilysin (1:250). Transplanted 
EGCs were detected in red at specific rhodamine emission wavelength typical for PKH26GL tracker, according 
the manufacturer’s instructions. Slices were then counter-stained with Amylo-Glo® RTD™ to visualize fibrillar 
Aβ plaques according the manufacturer’s instructions. Species-appropriate FITC or TRITC conjugated antibodies 
(1:250) were applied for 2 h at room temperature, followed by washes in PBS and mounting with PBS/Glycerol 1:1.
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Western blot analysis. The expression of cyclooxygenase-2 (COX-2), ionized calcium-binding adapter 
molecule 1 (Iba-1), GFAP, and phosphor-tau protein was evaluated in homogenates obtained from both hip-
pocampi and frontal cortices isolated post-mortem in the different animal groups at different time point intervals. 
The cytosolic fraction was used for the analysis. Protein concentration was determined with Bio-Rad assay kit and 
equivalent amounts (50 μg) of each sample were separated under reducing conditions in 12% SDS-polyacrylamide 
minigel. The proteins were transferred onto nitrocellulose membrane according to the manufacturer’s instruc-
tions (Bio-Rad Laboratories, Hercules, CA, USA). Depending upon the experiments, the membranes were 
incubated for 1 h at room temperature with specific anti-COX-2 (1:1000); Iba-1 (1:1200); anti-GFAP (1:1000), 
phospho-tau602 (1:600), anti-β actin (1:100) primary antibodies followed by incubation with specific horserad-
ish peroxidase (HRP)-conjugate secondary antibodies. The immune complexes were developed using enhanced 
chemiluminescence detection reagents and the protein bands were densitometrically analyzed for relative quan-
tification with a GS-700 imaging densitometer.
Enzyme Linked Immunosorbent Assay (ELISA). Enzyme Linked-Immuno-Sorbent Assay (ELISA) 
assay was carried out in both hippocampus and frontal cortex homogenates isolated post-mortem in the different 
groups at different time point intervals. According to each respective manufacturer’s instructions, ELISA assay 
for the quantification of TNFα , IL-6, PGE2, GDNF, BDNF and NGF was performed. In other experiments, ELISA 
for Aβ quantification in the cerebrospinal fluid (CSF) and in whole brain homogenates was performed according 
to manufacturer’s instructions.
Statistical analyses. All values are expressed as the mean ± SEM. Statistical differences were determined to 
be significant at P < 0.05. The specific tests used are described in the figure legends. All analyses were performed 
using GraphPad Prism software (GraphPad Software, Inc., CA USA). The investigators were not blinded to allo-
cation during experiments and outcome assessment.
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